2951 - 2960 of 6230 Results
Title
Year
-
OPENTitle: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 11Start Page: 1543End Page: 1551Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186Best OA location URL: https://europepmc.org/articles/pmc5510653?pdf=renderCitation Count: 9
-
OPENTitle: Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 15End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.005Best OA location URL: http://www.prd-journal.com/article/S1353802020300055/pdfCitation Count: 1
-
OPENTitle: Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brainJournal Name: Brain PathologyPublisher: WileyVol: 33Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.13196Best OA location URL: https://escholarship.org/content/qt18q71573/qt18q71573.pdfCitation Count: 11
-
OPENTitle: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule bindingJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 17Start Page: 1759End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220161Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/17/1759/936843/bcj-2022-0161.pdfCitation Count: 93
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
-
OPENTitle: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1Journal Name: European Journal of NeurosciencePublisher: WileyVol: 57Issue #: 5Start Page: 739End Page: 761Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.15917Citation Count: 2
-
OPENTitle: Structure-based design and characterization of Parkin-activating mutationsJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 6Issue #: 6Start Page: e202201419End Page: e202201419Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202201419Best OA location URL: https://www.life-science-alliance.org/content/lsa/6/6/e202201419.full.pdfCitation Count: 23
-
OPENTitle: Sex differences in the diagnosis latency of Parkinson's disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107344End Page: 107344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107344Citation Count: 0
-
OPENTitle: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00189-4Best OA location URL: https://www.nature.com/articles/s41531-021-00189-4.pdfCitation Count: 45
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://cdn.elifesciences.org/articles/12813/elife-12813-v2.pdfCitation Count: 925